3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Sponsor Class
INDUSTRY
2
Study Type
Observational
2
Sponsor
Conditions
Multiple Sclerosis
2
Carcinoma in Situ
2
Sarcoma, Kaposi
1
Multiple Sclerosis, Relapsing-Remitting
1
Multiple Sclerosis, Chronic Progressive
1
HIV Infections
1
Acquired Immunodeficiency Syndrome
1
Interventions
Interferon beta-1b
2
Fingolimod Hydrochloride
2
teriflunomide
1
nabiximols
1
Platelet Transfusion
1
OM 89
1
Natalizumab
1
Mn-PyC3A
1
Magnetic Resonance Imaging
1
Interferon beta-1a
1
Fish Oils
1
Dimethyl Fumarate
1
Blood Specimen Collection
1
Alemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Multiple Sclerosis
×
Interferon beta-1b
×
Clear all
NCT02486640
2023-07-24
BETAPREDICT
Bayer
Completed
162 enrolled
NCT03134573
2019-03-26
PROmyBETAapp
Bayer
Completed
96 enrolled